Tech

Xbox gaming console saves researchers thousands

Xbox gaming console  saves researchers thousands

A new study by a University of Warwick researcher has demonstrated that researchers trying to model a range of processes could use the power and capabilities of a particular XBox chip as a much cheaper alternative to other forms of parallel processing hardware.

Dual simulation improves crash performance

Dual simulation improves crash performance

Opto-electronic nose sniffs out toxic gases

Opto-electronic nose sniffs out toxic gases

CHAMPAIGN, Ill. — Imagine a polka-dotted postage stamp that can sniff out poisonous gases or deadly toxins simply by changing colors.

Electronic nose sniffs out toxins

Electronic nose sniffs out toxins

Imagine a polka-dotted postage stamp-sized sensor that can sniff out some known poisonous gases and toxins and show the results simply by changing colors.

Laser treatment for BRVO is safer than corticosteroid injections and equally effective

Scientists have found that laser therapy is equivalent to two different dosages of corticosteroid medications for treating vision loss from the blockage of small veins in the back of the eye, a condition known as branch retinal vein occlusion (BRVO). Furthermore, laser treatment was shown to have fewer complications for patients.

This research was part of the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study, a phase III clinical trial conducted at 84 sites and supported by the National Eye Institute (NEI) at the National Institutes of Health.

New treatment found to reduce vision loss from central retinal vein occlusion

Scientists have identified the first long-term, effective treatment to improve vision and reduce vision loss associated with blockage of large veins in the eye. This research was part of a multi-center, phase III clinical trial supported by the National Eye Institute (NEI) at the National Institutes of Health.

Burn treatment is improving thanks to nanotechnology

Treating second-degree burns with a nanoemulsion lotion sharply curbs bacterial growth and reduces inflammation that can otherwise jeopardize recovery, University of Michigan scientists have shown in initial laboratory studies.

U-M burn surgeon Mark R. Hemmila, M.D., reports today at the Interscience Conference for Antimicrobial Agents and Chemotherapy on results achieved with a nanoemulsion developed at U-M and licensed by U-M to Ann Arbor-based NanoBio Corporation.

Hormone promises to keep joint injuries from causing long-term osteoarthritis

An existing osteoporosis drug is the first ever found to prevent cartilage loss from osteoarthritis following injury to a joint, and may also regenerate some cartilage that has been lost to osteoarthritis, according to an early study presented today at the annual meeting of the American Society for Bone and Mineral Research in Denver. While the study was in mice, the model closely mimics human osteoarthritis that develops following knee injuries, according to the study authors.

Early results from clinical trials of 2009 H1N1 influenza vaccines in healthy adults

Mandatory alcohol testing for truck and bus drivers reduces alcohol involvement in fatal crashes